Olivera Story Jovanova,Ivana Nedeljkovic,Derek Spieler,Rosie M Walker,Chunyu Liu,Michelle Luciano,Jan Bressler,Jennifer Brody,Amanda J Drake,Kathryn L Evans,Rahul Gondalia,Sonja Kunze,Brigitte Kuhnel,Jari Lahti,Rozenn N Lemaitre,Riccardo E Marioni,Brenton Swenson,Jayandra Jung Himali,Hongsheng Wu,Yun Li,Allan F McRae,Tom C Russ,James Stewart,Zhiying Wang,Guosheng Zhang,Karl-Heinz Ladwig,Andre G Uitterlinden,Xiuqing Guo,Annette Peters,Katri Räikkönen,John M Starr,Melanie Waldenberger,Naomi R Wray,Eric A Whitsel,Nona Sotoodehnia,Sudha Seshadri,David J Porteous,Joyce van Meurs,Thomas H Mosley,Andrew M McIntosh,Michael M Mendelson,Daniel Levy,Lifang Hou,Johan G Eriksson,Myriam Fornage,Ian J Deary,Andrea Baccarelli,Henning Tiemeier,Najaf Amin

Abstract:Importance: Depressive disorders arise from a combination of genetic and environmental risk factors. Epigenetic disruption provides a plausible mechanism through which gene-environment interactions lead to depression. Large-scale, epigenome-wide studies on depression are missing, hampering the identification of potentially modifiable biomarkers. Objective: To identify epigenetic mechanisms underlying depression in middle-aged and elderly persons, using DNA methylation in blood. Design, setting, and participants: To date, the first cross-ethnic meta-analysis of epigenome-wide association studies (EWAS) within the framework of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium was conducted. The discovery EWAS included 7948 individuals of European origin from 9 population-based cohorts. Participants who were assessed for both depressive symptoms and whole-blood DNA methylation were included in the study. Results of EWAS were pooled using sample-size weighted meta-analysis. Replication of the top epigenetic sites was performed in 3308 individuals of African American and European origin from 2 population-based cohorts. Main outcomes and measures: Whole-blood DNA methylation levels were assayed with Illumina-Infinium Human Methylation 450K BeadChip and depressive symptoms were assessed by questionnaire. Results: The discovery cohorts consisted of 7948 individuals (4104 [51.6%] women) with a mean (SD) age of 65.4 (5.8) years. The replication cohort consisted of 3308 individuals (2456 [74.2%] women) with a mean (SD) age of 60.3 (6.4) years. The EWAS identified methylation of 3 CpG sites to be significantly associated with increased depressive symptoms: cg04987734 (P = 1.57 × 10-08; n = 11 256; CDC42BPB gene), cg12325605 (P = 5.24 × 10-09; n = 11 256; ARHGEF3 gene), and an intergenic CpG site cg14023999 (P = 5.99 × 10-08; n = 11 256; chromosome = 15q26.1). The predicted expression of the CDC42BPB gene in the brain (basal ganglia) (effect, 0.14; P = 2.7 × 10-03) and of ARHGEF3 in fibroblasts (effect, -0.48; P = 9.8 × 10-04) was associated with major depression. Conclusions and relevance: This study identifies 3 methylated sites associated with depressive symptoms. All 3 findings point toward axon guidance as the common disrupted pathway in depression. The findings provide new insights into the molecular mechanisms underlying the complex pathophysiology of depression. Further research is warranted to determine the utility of these findings as biomarkers of depression and evaluate any potential role in the pathophysiology of depression and their downstream clinical effects.

Multi-Omics Integration Reveals Transcriptomic and Epigenetic Signatures Underlying Brain Structural Deficits in Major Depressive Disorder

Integrative omics analysis reveals epigenomic and transcriptomic signatures underlying brain structural deficits in major depressive disorder

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Epigenetic molecular underpinnings of brain structural-functional connectivity decoupling in patients with major depressive disorder

Neuroimaging and epigenetic analysis reveal novel epigenetic loci in major depressive disorder

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

Connectome Analysis of Functional and Structural Hemispheric Brain Networks in Major Depressive Disorder

Gene Expression Analysis of Multiple Brain Regions in Major Depressive Disorder

Elucidating genetic and molecular basis of altered higher-order brain structure-function coupling in major depressive disorder

Transcriptomic decoding of regional cortical vulnerability to major depressive disorder

Investigating the Epigenetic Landscape of Major Depressive Disorder: A Genome-Wide Meta-Analysis of DNA Methylation Data, Including New Insights into Stochastic Epigenetic Mutations and Epivariations

Twenty-Five Cohorts of Major Depressive Disorder in China: Evidence for Reduced But Not Enhanced Default Mode Network Functional Connectivity

Transcriptional and Cellular Signatures of Morphometric Similarity Remodeling in Major Depressive Disorder

Integrative analyses of scRNA-seq, bulk mRNA-seq, and DNA methylation profiling in depressed suicide brain tissues

Cortical Structural Differences in Major Depressive Disorder Correlate with Cell Type-Specific Transcriptional Signatures

Connectome gradient dysfunction in major depression and its association with gene expression profiles and treatment outcomes

Genome-wide profiling of DNA methylome and transcriptome in peripheral blood monocytes for major depression: A Monozygotic Discordant Twin Study

A pilot exploration of multi-omics research of gut microbiome in major depressive disorders

DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies

Altered intersubject functional variability of brain white‐matter in major depressive disorder and its association with gene expression profiles